Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort
Clin Pharmacokinet. 2024 Jul 16. doi: 10.1007/s40262-024-01399-8. Online ahead of print. ABSTRACT INTRODUCTION AND OBJECTIVE: Pazopanib is registered for metastatic renal cell carcinoma and soft-tissue …